We see above the middle east has milestones of roughly half that of the EU deal. However, EU has significantly more patients than middle east / UAE at roughly 85,000. Middle east market didnt even score a mention in the investor market size presso.
So, with the EU deal done prefutility, and the middle east done after, there's a huge difference in negotiation outcome / leverage.
NB: dont pencil in the USA and China as being the remaining 70% market and therefore give that 70% deal value of whats already been made at about $300m. No. The remaining 70% in milestone agreement deal terms could be more like $50-$100m+ upfront. $1.5B+ in milestones
DXB - Research & Valuation, page-129
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.035(6.67%) |
Mkt cap ! $308.1M | |||
| Open | High | Low | Value | Volume |
| 51.5¢ | 57.3¢ | 50.5¢ | $2.179M | 3.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30558 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |